Stockreport

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

Purple Biotech Ltd. - American Depositary Shares  (PPBT) 
PDF IM1240 demonstrated improved  safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator IM1240's pharmacokinetic profile showed increased [Read more]